Toronto Dominion Bank Sells 252,428 Shares of MEDNAX Inc (MD)
Toronto Dominion Bank decreased its holdings in shares of MEDNAX Inc (NYSE:MD) by 34.9% in the 4th quarter, Holdings Channel reports. The firm owned 471,500 shares of the company’s stock after selling 252,428 shares during the period. Toronto Dominion Bank’s holdings in MEDNAX were worth $25,197,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Prudential Financial Inc. lifted its stake in MEDNAX by 976.9% in the third quarter. Prudential Financial Inc. now owns 641,057 shares of the company’s stock valued at $27,642,000 after acquiring an additional 581,527 shares during the last quarter. Quantbot Technologies LP acquired a new stake in MEDNAX in the third quarter valued at $695,000. Point72 Asset Management L.P. lifted its stake in MEDNAX by 71.7% in the third quarter. Point72 Asset Management L.P. now owns 132,700 shares of the company’s stock valued at $5,722,000 after acquiring an additional 55,400 shares during the last quarter. Nomura Holdings Inc. acquired a new stake in MEDNAX in the second quarter valued at $347,000. Finally, Advisor Group Inc. lifted its stake in MEDNAX by 41.9% in the third quarter. Advisor Group Inc. now owns 8,361 shares of the company’s stock valued at $359,000 after acquiring an additional 2,468 shares during the last quarter. Institutional investors and hedge funds own 95.22% of the company’s stock.
In other MEDNAX news, insider John C. Pepia sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The shares were sold at an average price of $51.58, for a total value of $154,740.00. Following the transaction, the insider now directly owns 35,569 shares of the company’s stock, valued at approximately $1,834,649.02. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.40% of the stock is owned by company insiders.
MEDNAX (NYSE:MD) last released its earnings results on Thursday, February 8th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.83 by $0.04. MEDNAX had a net margin of 9.26% and a return on equity of 10.10%. The firm had revenue of $910.82 million for the quarter, compared to analyst estimates of $884.55 million. During the same period last year, the firm earned $1.00 EPS. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. analysts anticipate that MEDNAX Inc will post 3.67 EPS for the current year.
A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of MEDNAX from $46.00 to $55.00 and gave the stock a “neutral” rating in a research note on Monday. Jefferies Group restated a “hold” rating and set a $44.00 target price on shares of MEDNAX in a research note on Friday, November 3rd. Mizuho restated a “neutral” rating and set a $53.00 target price (up previously from $49.00) on shares of MEDNAX in a research note on Friday, February 9th. BMO Capital Markets raised their target price on shares of MEDNAX from $46.00 to $58.00 and gave the stock a “market perform” rating in a research note on Monday. Finally, Stephens set a $62.00 target price on shares of MEDNAX and gave the stock a “buy” rating in a research note on Thursday, February 8th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $54.92.
WARNING: This piece of content was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.watchlistnews.com/toronto-dominion-bank-sells-252428-shares-of-mednax-inc-md/1866132.html.
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.